You should send Prof Nikki Verrills and email and let her know she's just wasted her time figuring out the Optimal combination of Zan/dec in a "Human patient derived model" It showed strong efficacy against AML and increased survival in a highly translatable model. No big deal.
RAC have been clear from day 1, they don't want to take this to market, they are building the data warehouse and handing the package over to BP.
The Market might want Clinical results, all we need is validation.
General Comments / Chat, page-7809
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |